Corbadrine
 | |
| Systematic (IUPAC) name | |
|---|---|
| 4-[(1R,2S)-2-amino-1-hydroxypropyl]benzene-1,2-diol | |
| Clinical data | |
| |
| Identifiers | |
829-74-3  | |
| None | |
| PubChem | CID 164739 |
| IUPHAR ligand | 508 |
| DrugBank |
DB06707  |
| ChemSpider |
144416 |
| UNII |
V008L6478D |
| KEGG |
D02388 |
| ChEMBL |
CHEMBL677 |
| Chemical data | |
| Formula | C9H13NO3 |
| 183.204 g/mol | |
|
SMILES
| |
| |
| (what is this?) (verify) | |
Corbadrine (INN; marketed as Neo-Cobefrine), also known as levonordefrin (USAN) and α-methylnorepinephrine, is a catecholamine sympathomimetic used as a topical nasal decongestant and vasoconstrictor in dentistry in the United States.[1][2]
Corbadrine is also an active metabolite of the antihypertensive drug methyldopa, and plays a role in its pharmacology and effects.
See also
- α-Methyldopamine
- α-Methyltyramine
References
- ↑ Dr. Ian Morton; I.K. Morton; Judith M. Hall (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 164–. ISBN 978-0-7514-0499-9.
- ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 275–. ISBN 978-3-88763-075-1.
External links
- Nordefrin at the US National Library of Medicine Medical Subject Headings (MeSH)
| ||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||